Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Molecular aspects of medicine - 34(2013), 6 vom: Dez., Seite 1217-1256 |
| Beteiligte Personen: |
Curtin, Nicola J. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
40 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1930308205 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1930308205 | ||
| 003 | DE-627 | ||
| 005 | 20230515223218.0 | ||
| 007 | tu | ||
| 008 | 131119s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw131025_1 |
| 035 | |a (DE-627)OLC1930308205 | ||
| 035 | |a (DE-599)GBVOLC1930308205 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 082 | 0 | 4 | |a 610 |q AVZ |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Curtin, Nicola J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond |
| 264 | 1 | |c 2013 | |
| 300 | |a 40 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Szabo, Csaba |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular aspects of medicine |d Amsterdam : Elsevier, 1978 |g 34(2013), 6 vom: Dez., Seite 1217-1256 |w (DE-627)129451037 |w (DE-600)197640-0 |w (DE-576)014816326 |x 0098-2997 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2013 |g number:6 |g month:12 |g pages:1217-1256 |g extent:40 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 34 |j 2013 |e 6 |c 12 |h 1217-1256 |g 40 | ||